A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.


Updates from The Motley Fool

Latest updates on Medivation from Fool.com.  The Fool has written over 200 articles on Medivation.
3 Top Stocks For Retirees

ExxonMobil, Microsoft, and Pfizer are top stocks that offer retirees an attractive blend of risk,...



Stock Performance

View Interactive MDVN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Medivation.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David T. Hung, MD, CEO

96% Approve

Based on 37 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Medivation.

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers